Publicly-traded company NextCure Inc. (NASDAQ:NXTC) had a closing price of $92.22 yesterday. Meanwhile, the average 12-month price target from Wall Street analysts is currently $43.67, this means that the stock is overpriced by -111.17%. In the past 52 weeks the company’s stock price has moved within the range of $13.86 to $44.69.
This particular stock’s 5-day moving average is 39.37, its 20-day moving average is 29.79 and its 100-day moving average is 26.60. NextCure Inc. (NXTC) currently has 20.76M shares outstanding, which means that its market capitalization is $1.91B.
What Does Wall Street Say about Company?
When choosing stocks, many investors search for what Wall Street professionals think about the company first – like what the average rating is. At the moment, the average analyst rating for NXTC is Buy. Out of 3 total analysts who were surveyed, 0 rated it a sell, 0 rated it a underweight, 0 rated it an overweight, 0 rated it hold, and 3 rated it a Buy.
Understanding Profitability at NextCure Inc. (NXTC)
Taking a look at a public company’s Earnings per Share (EPS) is a good way of evaluating its profitability. In the most recent financial results released by NextCure Inc., for the quarter ending on 09/2019, the company posted EPS of -0.35. The average estimate of Wall Street analysts had projected -0.34.